SEARCH

SEARCH BY CITATION

References

  • 1
    Denoix P. Epidémiologie générale du cancer primitif du foie. In: Les cancers primitifs du foie. Paris: Masson, 1976: 3342.
  • 2
    BeasleyR P, LinC-C, HwangL-Y, ChienC-S. Risk of hepatocellular carcinoma in hepatitis B virus infections: a prospective study in Taiwan. In: SzmunessW., AlterH J, MaynardJ E eds. Viral hepatitis. Philadelphia: The Franklin Institute Press, 1982: 261270.
  • 3
    Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 1978: 24: 4069.
  • 4
    Prince A M, Szmuness W., Michon J., et al. A case/control study of the association between primary liver cancer and hepatitis B infection in Senegal. Int J Cancer 1975: 16: 376383.
  • 5
    Payet M., Sankale M., Saimot G., Larouze B., Brochard C. Facteurs étiologiques du cancer primitif du foie. Place de l'antigène Australia. In: Les cancers primitifs du foie. Paris: Masson, 1976: 732.
  • 6
    Shafritz D A, Shouval D., Sherman H J, Hadziyannis S J, Kew M C. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma; studies in percutaneous liver biopsies and postmortem tissue specimens. N Engl J Med 1981: 305: 10671073.
  • 7
    RizzettoM., BoninoF., VermeG., PurcellR H, GerinJ L. Nomenclature: A proposal to designate the delta agent as hepatitis D virus. In: VermeG., BoninoF., RizzettoM. eds. Delta infection and viral hepatitis. Progress in Clinical and Biological Research, vol. 143. New York: Alan R Liss, 1983: XXXXI.
  • 8
    Rizzetto M., Canese M G, Arico S., Crivelli O., Bonino F., Trepo C G, Verme G. Immunofluorescence detection of a new antigen-antibody system (delta/anti-delta) associated to the hepatitis B virus in the liver and in serum of HBsAg carriers. Gut 1977: 18: 9971003.
  • 9
    Rizzetto M., Purcell R H, Gerin J L. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in poly-transfused HBsAg carriers. Lancet 1980: i: 12151219.
  • 10
    Raimondo G., Smedile A., Gallo L., Balbo A., Ponzetto A., Rizzetto M. Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. Lancet 1982: i: 249251.
  • 11
    HanssonB G, NorkransG., WeibullM., et al. Epidemiology of delta infection in Scandinavia. In: VermeG., BoninoF., RizzettoM. eds. Delta infection and viral hepatitis. Progress in Clinical and Biological Research, vol. 143. New York: Alan R Liss, 1983.
  • 12
    Hoy J F, Hansson B G, Dimitrakakis M., Gust I., Lucas C R. Delta agent infection in Melbourne. J Med Virol. in press.
  • 13
    Hansson B G. Age- and sex-related distribution of antibodies to hepatitis B surface and core antigens in a Swedish population. Acta Pathol Microbiol Scand (Sect B) 1976: 84: 342346.
  • 14
    Rizzetto M., Shih J W K, Gerin J L. The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassay for delta antigen and anti-delta and partial characterization of delta antigen. J Immunol 1980: 125: 318324.
  • 15
    Hansson B G, Moestrup T., Widell A., Nordenfelt E. Infection with delta antigen in Sweden; introduction of a new hepatitis agent. J Infect Dis 1982: 146: 472478.
  • 16
    Govindarajan G., Hevia F J, Peters R L. Prevalence of delta antigen/antibody in B viral induced hepatocellular carcinoma. Cancer. in press.
  • 17
    CraxiA., RaimondoG., GiannuoliG., et al. Delta agent and hepatocellular carcinoma. In: VermeG., BoninoF., RizzettoM. eds. Delta infection and viral hepatitis. Progress in Clinical and Biological Research, vol. 143, New York: Alan R Liss, 1983: 231234.
  • 18
    HadziyannisS J. Delta antigen positive chronic liver disease in Greece: clinical aspects and natural course. In: VermeG., BoninoF., RizzettoM. eds. Delta infection and viral hepatitis. Progress in Clinical and Biological Research, vol. 143, New York: Alan R Liss, 1983: 209217.